tiprankstipranks
Pharming Group Nv (PHAR)
NASDAQ:PHAR
US Market
Want to see PHAR full AI Analyst Report?

Pharming Group (PHAR) Financial Statements

234 Followers

Pharming Group Financial Overview

Pharming Group's market cap is currently $823.42M. The company's EPS TTM is $0.138; its P/E ratio is 80.71; Pharming Group is scheduled to report earnings on July 30, 2026, and the estimated EPS forecast is $0.11. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 376.13M$ 297.20M$ 245.32M$ 205.62M$ 198.87M
Gross Profit$ 330.63M$ 261.80M$ 220.10M$ 188.06M$ 177.73M
Operating Income$ 20.88M$ -3.67M$ -22.29M$ 9.86M$ 19.01M
EBITDA$ 34.78M$ 16.32M$ 9.88M$ 33.53M$ 48.78M
Net Income$ 2.85M$ -11.84M$ -10.55M$ 13.67M$ 16.00M
Balance Sheet
Cash & Short-Term Investments$ 179.81M$ 173.85M$ 213.42M$ 207.34M$ 217.59M
Total Assets$ 499.81M$ 414.18M$ 462.85M$ 425.80M$ 450.44M
Total Debt$ 115.78M$ 116.30M$ 171.54M$ 166.69M$ 183.39M
Net Debt$ -30.25M$ 59.41M$ 109.80M$ -40.65M$ -34.20M
Total Liabilities$ 222.79M$ 185.27M$ 244.07M$ 221.16M$ 231.73M
Stockholders' Equity$ 277.02M$ 228.91M$ 218.78M$ 204.64M$ 218.71M
Cash Flow
Free Cash Flow$ 53.95M$ -2.59M$ -18.77M$ 20.48M$ 21.13M
Operating Cash Flow$ 54.71M$ -1.79M$ -17.30M$ 22.46M$ 37.84M
Investing Cash Flow$ 26.25M$ 31.62M$ -129.39M$ 5.32M$ -21.30M
Financing Cash Flow$ 1.50M$ -34.41M$ -1.04M$ -4.98M$ -27.95M

Pharming Group Earnings and Revenue History

Pharming Group Debt to Assets

Pharming Group Cash Flow

Pharming Group Forecast EPS vs Actual EPS